The FDA has approved Inlexzo, the first intravesical drug-releasing device for bladder cancer, offering an alternative for patients whose disease no longer responds to BCG therapy. The device delivers ...
Sanofi Pasteur said it’s discontinuing the manufacture of TheraCys, an important bladder cancer drug, and shortages are expected, while the US Food and Drug Administration (FDA) on Friday released ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results